Encyclia Pharmaceuticals Private Limited, a active private limited company, was established on 05 November 2012 in Delhi, Delhi, India. Engaging in corporate training & development within the construction sector, it holds CIN: U80100DL2012PTC244482. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹1.80 M.
Formerly known as Encyclia Private Limited, Excalibur Learning Private Limited. It upholds a compliant status. Its leadership includes Koushlia Devi (Additional Director), Atish Kumar (Director). Past directors included Adesh Kumar, Pramod. It holds ₹2.02 M open charges and ₹5.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 15/42 Old Rajendra Nagar I Floor Near Gol Chakkar, Delhi, Delhi, 110060.
U80100DL2012PTC244482
244482
05 November 2012
₹5.00 M
₹1.80 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Encyclia Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Koushlia Devi | Additional Director | 18 Aug 2023 | Current |
| Atish Kumar | Director | 05 Nov 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 23 Aug 2023 | Past |
| Pramod Abcsdd | Director | 12 Dec 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Encyclia Pharmaceuticals Private Limited, for the financial year ended 2019, experienced Minor drop in revenue, with a 8.03% decrease. The company also saw a substantial improvement in profitability, with a 143.58% increase in profit. The company's net worth Soared by an impressive increase of 17.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Encyclia Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,020,000.00
₹5,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 May 2019 | Others | ₹2.02 M | Open |
| 04 Mar 2013 | Punjab National Bank | ₹5.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Encyclia Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Encyclia Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Encyclia Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Encyclia Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Encyclia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Progress on Koushlia Devi was appointed as a Additional Director was appointed as a Additional Director on 18 Aug 2023 & has been associated with this company since 2 years 4 months . was documented.
Progress on A charge with Others amounted to Rs. 2.02 M with Charge ID 100269635 was registered on 27 May 2019. was documented.
Progress on A charge registered on 04 Mar 2013 via Charge ID 10414977 with Punjab National Bank was fully satisfied on 24 Mar 2017. was documented.
Progress on A charge with Punjab National Bank amounted to Rs. 5.00 M with Charge ID 10414977 was registered on 04 Mar 2013. was documented.
The CIN of Encyclia Pharmaceuticals Private Limited is U80100DL2012PTC244482.
Encyclia Pharmaceuticals Private Limited is headquartered at 15/42 Old Rajendra Nagar I Floor Near Gol Chakkar, Delhi, Delhi, 110060.
Encyclia Pharmaceuticals Private Limited was incorporated on 05 November 2012.
The current directors of Encyclia Pharmaceuticals Private Limited are
The primary industry of Encyclia Pharmaceuticals Private Limited is Construction.
Encyclia Pharmaceuticals Private Limited is unlisted.
The authorized capital of Encyclia Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹1.80 M.
The compliance status of Encyclia Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX